Literature DB >> 17923791

Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals.

G Murdolo1, K Kempf, A Hammarstedt, C Herder, U Smith, P-A Jansson.   

Abstract

Human obesity has been associated with a dysregulation of the peripheral and adipose tissue (AT) endocannabinoid system (ES). The aim of this study was to elucidate the acute in vivo effects of insulin on gene expression of the cannabinoid type 1 (CB-1) and type 2 (CB-2) receptors, as well as of the fatty acid amide hydrolase (FAAH) in the sc abdominal adipose tissue (SCAAT). Nine lean (L) and 9 obese (OB), but otherwise healthy males were studied in the fasting state and during a euglycemic hyperinsulinemic clamp (40 mU/m2 * min(-1)). SCAAT biopsies were obtained at baseline and after 270 min of i.v. maintained hyperinsulinemia. The basal SCAAT gene expression pattern revealed an upregulation of the FAAH in the OB (p=0.03 vs L), whereas similar CB-1 and CB-2 mRNA levels were seen. Following hyperinsulinemia, the FAAH mRNA levels significantly increased approximately 2-fold in the L (p=0.01 vs baseline) but not in the OB. In contrast, insulin failed to significantly change both the adipose CB-1 and CB-2 gene expression. Finally, the FAAH gene expression positively correlated with the fasting serum insulin concentration (r 0.66; p=0.01), whereas an inverse association with the whole-body glucose disposal (r -0.58; p<0.05) was seen. Taken together, these first time observations demonstrate that the ES-related genes in the SCAAT differentially respond to hyperinsulinemia in lean/insulin-sensitive and in obese/insulin-resistant individuals. We suggest that insulin may play a key role in the obesity-linked dysregulation of the adipose ES at the gene level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923791     DOI: 10.1007/BF03347440

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

Review 1.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.

Authors:  B Spoto; F Fezza; G Parlongo; N Battista; E Sgro'; V Gasperi; C Zoccali; M Maccarrone
Journal:  Biochimie       Date:  2006-08-22       Impact factor: 4.079

Review 3.  Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies.

Authors:  F Giorgino; L Laviola; J W Eriksson
Journal:  Acta Physiol Scand       Date:  2005-01

Review 4.  Endocannabinoids and the control of energy balance.

Authors:  Isabel Matias; Vincenzo Di Marzo
Journal:  Trends Endocrinol Metab       Date:  2006-12-01       Impact factor: 12.015

5.  Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes.

Authors:  Régis Roche; Laurence Hoareau; Sandrine Bes-Houtmann; Marie-Paule Gonthier; Christine Laborde; Jean-François Baron; Yacine Haffaf; Maya Cesari; Franck Festy
Journal:  Histochem Cell Biol       Date:  2006-01-04       Impact factor: 4.304

Review 6.  The emerging role of the endocannabinoid system in endocrine regulation and energy balance.

Authors:  Uberto Pagotto; Giovanni Marsicano; Daniela Cota; Beat Lutz; Renato Pasquali
Journal:  Endocr Rev       Date:  2005-11-23       Impact factor: 19.871

7.  Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation.

Authors:  Monsif Bouaboula; Sandrine Hilairet; Jean Marchand; Lluis Fajas; Gerard Le Fur; Pierre Casellas
Journal:  Eur J Pharmacol       Date:  2005-07-11       Impact factor: 4.432

8.  The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression.

Authors:  K Kempf; B Rose; C Herder; B Haastert; A Fusbahn-Laufenburg; A Reifferscheid; W A Scherbaum; H Kolb; S Martin
Journal:  J Mol Med (Berl)       Date:  2006-12-12       Impact factor: 4.599

9.  The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.

Authors:  M Bensaid; M Gary-Bobo; A Esclangon; J P Maffrand; G Le Fur; F Oury-Donat; P Soubrié
Journal:  Mol Pharmacol       Date:  2003-04       Impact factor: 4.436

10.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

Authors:  Daniela Cota; Giovanni Marsicano; Matthias Tschöp; Yvonne Grübler; Cornelia Flachskamm; Mirjam Schubert; Dorothee Auer; Alexander Yassouridis; Christa Thöne-Reineke; Sylvia Ortmann; Federica Tomassoni; Cristina Cervino; Enzo Nisoli; Astrid C E Linthorst; Renato Pasquali; Beat Lutz; Günter K Stalla; Uberto Pagotto
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

View more
  20 in total

Review 1.  Endocannabinoids and Stroke Prevention: Review of Clinical Studies.

Authors:  Eugene L Scharf; Jon O Ebbert
Journal:  Cannabis Cannabinoid Res       Date:  2020-02-27

Review 2.  Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle.

Authors:  Cristoforo Silvestri; Alessia Ligresti; Vincenzo Di Marzo
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

3.  Quercetin suppresses MIP-1α-induced adipose inflammation by downregulating its receptors CCR1/CCR5 and inhibiting inflammatory signaling.

Authors:  Hye-Ji Noh; Chu-Sook Kim; Ji-Hye Kang; Jun-Young Park; Suck-Young Choe; Soon-Myoung Hong; Hoon Yoo; Taesun Park; Rina Yu
Journal:  J Med Food       Date:  2013-12-10       Impact factor: 2.786

Review 4.  The dysregulation of the endocannabinoid system in diabesity-a tricky problem.

Authors:  Thomas Scherer; Christoph Buettner
Journal:  J Mol Med (Berl)       Date:  2009-03-17       Impact factor: 4.599

Review 5.  The endocannabinoid system in obesity and type 2 diabetes.

Authors:  V Di Marzo
Journal:  Diabetologia       Date:  2008-06-18       Impact factor: 10.122

6.  Obesity-related dyslipidemia associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent.

Authors:  Yi Zhang; Gabriele E Sonnenberg; Tesfaye Mersha Baye; Jack Littrell; Jennifer Gunnell; Ann DeLaForest; Erin MacKinney; Cecilia J Hillard; Ahmed H Kissebah; Michael Olivier; Russell A Wilke
Journal:  Pharmacogenomics       Date:  2009-12       Impact factor: 2.533

7.  Factors associated with fasting plasma ghrelin levels in children and adolescents.

Authors:  Chao-Chun Zou; Li Liang; Zheng-Yan Zhao
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

8.  Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.

Authors:  Giovanni Annuzzi; Fabiana Piscitelli; Lucrezia Di Marino; Lidia Patti; Rosalba Giacco; Giuseppina Costabile; Lutgarda Bozzetto; Gabriele Riccardi; Roberta Verde; Stefania Petrosino; Angela A Rivellese; Vincenzo Di Marzo
Journal:  Lipids Health Dis       Date:  2010-04-28       Impact factor: 3.876

Review 9.  Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.

Authors:  Elizabeth J Rahn; Andrea G Hohmann
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding.

Authors:  Angelo A Izzo; Fabiana Piscitelli; Raffaele Capasso; Gabriella Aviello; Barbara Romano; Francesca Borrelli; Stefania Petrosino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.